Details From Head-to-Head Phase 3 Test Give Fuller Picture of Zepbound’s Edge Over Wegovy

Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisk’s Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting. The post Details From Head-to-Head Phase 3 Test Give Fuller…

Read More

Reducing Care Gaps Through Payer Insights

[Sponsored] Megan Zakrewsky, Vice President of Product, talked about how Veradigm is working with primary care providers to provide timely patient information without adding to their administrative burden. The post Reducing Care Gaps Through Payer Insights appeared first on MedCity News.

Read More

How One Health System Drove Revenue Gains with Ambient Listening

Riverside Health is reporting an increase in revenue and net margins as a result of adopting Abridge’s ambient AI technology. The tool listens to doctor-patient interactions and generates clinical notes — which not only alleviates physicians’ burnout, but also improves their documentation accuracy. The Virginia-based health system saw a 14% increase in HCC diagnoses documented…

Read More